Medical News

RSS

Positive results from pivotal Phase 3 trials of BENLYSTA in SLE patients

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced topline secondary endpoints from BLISS-76, the second of two pivotal Phase 3 trials of BENLYSTA™ (belimumab) in seropositive patients with systemic lupus erythematosus.

20 Apr 2010

TYSABRI drives Biogen Idec's first-quarter revenues of $1.1 billion

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its first quarter 2010 results.

20 Apr 2010

New web-based service for analyzing, visualizing and managing DNA sequencing data

DNAnexus, Inc. today announced the commercial launch of its web-based service for analyzing, visualizing, and managing next-generation DNA sequencing data. Andreas Sundquist, Ph.D., co-founder and CEO, will introduce the solution publicly for the first time today at the annual Bio-IT World Conference and Expo in Boston, Massachusetts.

20 Apr 2010

Genentech to pay Seattle Genetics $9.5M for renewing licenses under existing ADC collaboration agreement

Seattle Genetics, Inc. today announced that Genentech, Inc., a wholly owned member of the Roche Group, will pay $9.5 million to renew exclusive licenses to specific targets and extend the research term under the parties' existing antibody-drug conjugate (ADC) collaboration agreement. Under the terms of the agreement, Genentech has rights to use Seattle Genetics' ADC technology with antibodies against targets selected by Genentech.

20 Apr 2010

Total Pricing Systems of Moncton introduces PPS Assist!

Total Pricing Systems of Moncton, a leading communication services supplier to the pharmaceutical and medical device industry since 1991, has introduced Canada's first industry communication delivery and management approach that will significantly reduce the industries' ecological footprint while also donating money to health charities.

20 Apr 2010

MDx to better health care, cut costs and make personalized medicine a worldwide reality

The rapidly growing field of molecular diagnostics is addressing critical unmet needs in healthcare by enabling early disease detection and better disease segmentation, and by predicting relapse and response to therapy, according to a global industry review released today by Scientia Advisors.

20 Apr 2010

Acorda Therapeutics to initiate Phase 1 clinical trial of GGF2 for heart failure in mid-2010

Acorda Therapeutics, Inc. today announced plans to initiate a Phase 1 single-dose clinical trial of the Company's compound, Glial Growth Factor 2 (GGF2), in patients with heart failure in mid-2010, based on an IND filed with the U.S. Food and Drug Administration (FDA) on March 19, 2010. GGF2 has been shown to protect heart muscle and restore cardiac function in preclinical models of heart failure, myocardial infarction and cardiotoxicity.

20 Apr 2010

Investment report on Sequenom from MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring Sequenom Inc. The report includes financial, comparative and investment analysis, and industry information you need to know to make an educated investment decision.

20 Apr 2010

UMDNJ researchers receive $2.1M, four-year grant from National Cancer Institute

The University of Medicine and Dentistry of New Jersey-School of Public Health has received a $2.1 million, four-year grant from the National Cancer Institute. The grant will be used to develop and implement an innovative sampling approach designed to improve knowledge about tobacco use by young adults and associated use risk factors.

20 Apr 2010

Medical device industry leaders to meet with lawmakers, government officials at MDMA annual meeting

As the U.S. Food and Drug Administration is reviewing pivotal regulatory procedures for one of America's fastest growing sectors, industry leaders will gather to meet with lawmakers and government officials at the 16th Annual Meeting of the Medical Device Manufacturers Association on May 24-26, 2010 at the Park Hyatt in Washington, DC.

20 Apr 2010

First Edition: April 20, 2010

Today's headlines highlight coverage of the political implications of health reform as well as action taken by the nation's two largest insurers to meet a requirement of the new health law early.

20 Apr 2010

Platelet rich plasma helps speed healing and bone formation following tooth removal

The use of platelet rich plasma (PRP) following tooth removal appears to speed healing and bone formation, according to an article in the Journal of Oral Implantology.

20 Apr 2010

MUC1 expression indicates progression of pediatric inflammatory bowel disease

Millions of people are afflicted with inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, and 30 percent of new cases occur in childhood. Mucin 1, an epithelial mucin that has been shown to elicit both an immune response and to have altered glycosylation in disease, may be a noninvasive indicator of the progression of these illnesses.

20 Apr 2010

Affymetrix introduces new service for obtaining allele-specific copy number data from FFPE samples

Affymetrix, Inc. today announced the launch of the Affymetrix® MIP Copy Number Service, designed for cancer researchers using challenging FFPE samples. With the MIP Copy Number Service, scientists can now obtain high-quality allele-specific copy number data from FFPE samples. The service is available for research use only exclusively through the Affymetrix® Research Services Laboratory (ARSL).

20 Apr 2010

Cal/OSHA issues $101,485 in citations to Alta Bates Summit Medical Center in Oakland

The Department of Industrial Relations' Division of Occupational Safety and Health, better known as Cal/OSHA, today issued $101,485 in citations to Alta Bates Summit Medical Center in Oakland for ten violations of the state safety and health standards in connection to a life-threatening exposure of bacterial meningitis.

20 Apr 2010

AngioDynamics commences treatment in NanoKnife IRE System pilot study for HCC

AngioDynamics today announced the first patient treatment and growing enrollment in a pilot study of the use of the Company's NanoKnife® Irreversible Electroporation (IRE) System in the treatment of early stage hepatocellular carcinoma (HCC), or primary liver cancer. This clinical trial is being conducted under the supervision of Professor Jordi Bruix of the Barcelona Clinic Liver Cancer Group of the University of Barcelona and Professor Riccardo Lencioni of the University of Pisa School of Medicine.

20 Apr 2010

Biovest to make presentation on BiovaxID cancer vaccine at World Vaccine Congress 2010

Biovest International, Inc. today announced that the Company will be making a presentation regarding its personalized cancer vaccine, BiovaxID, on April 22 at the World Vaccine Congress which is currently ongoing in Washington D.C.

20 Apr 2010

STERIS reaches agreement with FDA over liquid chemical sterilization system consent decree

STERIS Corporation today announced it has reached an agreement with the U.S. Food and Drug Administration (FDA) on the terms of a consent decree regarding its SYSTEM 1® liquid chemical sterilization system. Included in the agreement is a Transition Plan with a Rebate Program for current SYSTEM 1 Customers in the U.S. The consent decree is subject to approval by the U.S. District Court for the Northern District of Ohio.

20 Apr 2010

Teva Pharmaceutical Industries presents ADAGIO study results at AAN Annual Meeting

Teva Pharmaceutical Industries Ltd. today announced results from the placebo group analyses of the ADAGIO study that were presented at the 62nd Annual Meeting of the American Academy of Neurology. The ADAGIO study stands out from other Parkinson's disease trials as it is the largest clinical study conducted in patients who were still in the very early stages of their disease course (average time from PD diagnosis of 4.5 months).

20 Apr 2010

Ovale malaria is two similar but distinct species that do not reproduce with each other: Research

Scientists investigating ovale malaria, a form of the disease thought to be caused by a single species of parasite, have confirmed that the parasite is actually two similar but distinct species which do not reproduce with each other, according to research published in The Journal of Infectious Diseases.

20 Apr 2010

Medical News

Positive results from pivotal Phase 3 trials of BENLYSTA in SLE patients

TYSABRI drives Biogen Idec's first-quarter revenues of $1.1 billion

New web-based service for analyzing, visualizing and managing DNA sequencing data

Genentech to pay Seattle Genetics $9.5M for renewing licenses under existing ADC collaboration agreement

Total Pricing Systems of Moncton introduces PPS Assist!

MDx to better health care, cut costs and make personalized medicine a worldwide reality

Acorda Therapeutics to initiate Phase 1 clinical trial of GGF2 for heart failure in mid-2010

Investment report on Sequenom from MicroStockProfit.com

UMDNJ researchers receive $2.1M, four-year grant from National Cancer Institute

Medical device industry leaders to meet with lawmakers, government officials at MDMA annual meeting

First Edition: April 20, 2010

Platelet rich plasma helps speed healing and bone formation following tooth removal

MUC1 expression indicates progression of pediatric inflammatory bowel disease

Affymetrix introduces new service for obtaining allele-specific copy number data from FFPE samples

Cal/OSHA issues $101,485 in citations to Alta Bates Summit Medical Center in Oakland

AngioDynamics commences treatment in NanoKnife IRE System pilot study for HCC

Biovest to make presentation on BiovaxID cancer vaccine at World Vaccine Congress 2010

STERIS reaches agreement with FDA over liquid chemical sterilization system consent decree

Teva Pharmaceutical Industries presents ADAGIO study results at AAN Annual Meeting

Ovale malaria is two similar but distinct species that do not reproduce with each other: Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News